Related Experiment Video
Updated: Aug 8, 2025

Quantification of Colonic Stem Cell Mutations
Published on: September 25, 2015
Microbiota-derived genotoxin tilimycin generates colonic stem cell mutations
Lisa Pöltl1, Maksym Kitsera1, Sandra Raffl1
1Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Abstract:
The DNA-alkylating metabolite tilimycin is a microbial genotoxin. Intestinal accumulation of tilimycin in individuals carrying til+ Klebsiella spp. causes apoptotic erosion of the epithelium and colitis. Renewal of the intestinal lining and response to injury requires the activities of stem cells located at the base of intestinal crypts. This study interrogates the consequences of tilimycin-induced DNA damage to cycling stem cells. We charted the spatial distribution and luminal quantities of til metabolites in Klebsiella-colonized mice in the context of a complex microbial community. Loss of marker gene G6pd function indicates genetic aberrations in colorectal stem cells that became stabilized in monoclonal mutant crypts. Mice colonized with tilimycin-producing Klebsiella displayed both higher frequencies of somatic mutation and more mutations per affected individual than animals carrying a non-producing mutant. Our findings imply that genotoxic til+ Klebsiella may drive somatic genetic change in the colon and increase disease susceptibility in human hosts.
Insights
Genotoxic bacteria like Klebsiella can cause DNA damage in intestinal stem cells, leading to mutations and increased disease risk. This study reveals how tilimycin, a bacterial toxin, impacts colon health.
Area of Science:
- Microbiology
- Genetics
- Gastroenterology
Background:
- The gut microbiome plays a crucial role in intestinal health.
- Certain bacteria produce genotoxins that can harm host cells.
- Intestinal stem cells are vital for tissue repair and regeneration.
Purpose of the Study:
- To investigate the effects of the DNA-alkylating genotoxin tilimycin on intestinal stem cells.
- To understand the link between tilimycin-producing Klebsiella and colorectal stem cell mutations.
- To assess the impact of genotoxic bacteria on somatic genetic changes in the colon.
Main Methods:
- Spatial distribution and quantification of tilimycin metabolites in colonized mice.
- Analysis of genetic aberrations in colorectal stem cells using marker gene G6pd.
- Comparison of mutation frequencies in mice colonized with tilimycin-producing versus non-producing Klebsiella.
Main Results:
- Tilimycin accumulation was observed in Klebsiella-colonized mice.
- Loss of G6pd function indicated genetic damage in colorectal stem cells, forming monoclonal mutant crypts.
- Mice with tilimycin-producing Klebsiella showed significantly higher frequencies and burdens of somatic mutations.
Conclusions:
- Genotoxic Klebsiella species can induce somatic genetic alterations in the colon.
- Tilimycin-induced DNA damage to stem cells may contribute to disease susceptibility.
- Understanding these microbial genotoxic effects is crucial for human gut health.
Related Concept Videos
Mutagenicity and Carcinogenicity
Spontaneous and Induced Mutations
Drugs that Destabilize Microtubules
Induced Pluripotent Stem Cells
Somatic...
In-vitro Mutagenesis

